For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it

Sponsorship complete. Dine on...

Nutrition, wellness, weight loss, and calmer healthy living.

Global Trial of Trontinemab Aims to Prevent Alzheimer's Disease Before Symptoms Appear

Oct 1, 2026
Global Trial of Trontinemab Aims to Prevent Alzheimer's Disease Before Symptoms Appear

In recent years, significant advancements have been made in the search for treatments for Alzheimer’s disease. Notably, a trial in 2022 for the drug lecanemab demonstrated that it could slow the progression of Alzheimer’s, while another drug, donanemab, also showed encouraging results. Building on this momentum, researchers at the NHS are set to initiate a new global trial known as the PrevenTRON study, which will investigate the effects of an experimental drug called trontinemab. This trial is particularly focused on individuals who do not exhibit memory loss or other symptoms of Alzheimer’s, with the goal of assessing whether the drug can delay or even prevent the disease from progressing to dementia.

As part of the study, healthy participants aged between 55 and 80 from various countries will undergo blood tests to measure levels of p-tau217, a biomarker that has been shown to predict cognitive decline and the potential development of Alzheimer’s. Previous research indicates that blood tests for p-tau217 can identify Alzheimer’s disease with up to 95% accuracy, and it is estimated that approximately 78% of individuals with this biomarker may develop cognitive impairment within a decade.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it

Sponsorship complete. Dine on...

Currently, Phase 3 of the trial is underway, involving around 1,600 participants from 18 countries who do not show symptoms of dementia but have elevated p-tau217 levels. The final results of the trial are not expected until at least 2028, when the current studies are projected to conclude.

Trontinemab, developed by the Swiss pharmaceutical company Roche, is designed to target amyloid plaques—harmful proteins that accumulate in the brain and damage brain cells over time. In Phase 2 of the trial, which included 100 individuals with early-stage Alzheimer’s, trontinemab successfully cleared amyloid plaques in 90% of participants within 28 weeks, suggesting its potential as a preventative treatment for those without symptoms.

Professor Ramin Nilforooshan, the chief investigator for the PrevenTRON trial, emphasized the shift in focus of research, stating, "For decades, research has concentrated on treating Alzheimer’s disease after symptoms appear. PrevenTRON addresses a different question: whether we can act earlier, before symptoms begin." This innovative approach could pave the way for new strategies in combating Alzheimer’s disease and improving the quality of life for millions at risk.

For Your Kitchen
Cookbooks
Taste it
Kitchen Scales
Taste it
Meal Prep Containers
Taste it
Vegetable Prep & Salad Spinners
Taste it

Sponsorship complete. Dine on...

For Your Kitchen
Cookbooks

Everyday recipes with room for flavor, variety, and real life. Dinner should not feel like homework.

Taste it
Kitchen Scales

Kitchen scales for recipes that deserve more precision than 'that looks about right.'

Taste it
Meal Prep Containers

Give tomorrow's lunch a proper home. Containers for meals worth looking forward to.

Taste it
Vegetable Prep & Salad Spinners

Salad spinners and vegetable-prep tools for everyday salads, bowls, and side dishes. A little less kitchen setup, a little more time to enjoy the meal.

Taste it
Blenders & Smoothie Tools

Blenders for fruit, yogurt, soups, and the combinations you actually enjoy. Everyday kitchen tools, not a promise in a glass.

Taste it
Sheet Pans & Roasting Essentials

Sheet pans and roasting racks for vegetables and simple oven meals. Useful equipment for dinner without an elaborate production.

Taste it

Sponsorship complete. Dine on...

Across our publications

In Other News

Latest stories from other publications.

Explore all publications (opens in a new tab)